Expertise
Public Health, Epidemiology (Clinical Epidemiology / Pharmacoepidemiology / Social Epidemiology), Healthcare Policy, Healthcare Industry Policy, Evidence-Based Policy Making (EBPM), Health and Productivity Management, Clinical Pharmacy
Education
- 2024.03 Master of Business Administration (MBA), Financial Strategy and Corporate Finance Program, Graduate School of Business Administration, Hitotsubashi University
- 2021.03 Master of Public Health (MPH), Department of Public Health, Graduate School of Medicine, The University of Tokyo
- 2013.03 Bachelor of Pharmacy (BPharm), Faculty of Pharmacy, Meijo Universit
Experience
- 2024.03 - Present Deputy Director, Healthcare Industries Division, METI
- 2022.04 - 2024.02 CancerScan Co., Ltd.
- 2020.08 - 2022.03 Datack Co., Ltd.
- 2019.08 - 2022.02 Hitotofrom Manmaru Pharmacy (Part-time, Concurrent Employment)
- 2013.04 - 2019.03 Nagoya Daini Red Cross Hospital
Selected Publications and Papers
- Impact of national guidelines for antimicrobial stewardship to reduce antibiotic use in upper respiratory tract infection and gastroenteritis, Infect Control Hosp Epidemiol, 2021 Mar;42(3):280-286.
- Mortality and morbidity following postoperative use of short-term, low-dose quetiapine vs risperidone in patients with diabetes: Analysis using a national inpatient database, Pharmacoepidemiol Drug Saf, 2020 Dec;29(12):1703-1709.
